TAVI Index Procedure: The Value of Valve Optimisation on Long-term Outcomes and Lifetime Management

Date: Wednesday, 9 April 2025
Time: 17:05 CEST | 11:05 EDT

Chair: Rui Teles, Carnaxide, PT
Panel: James Cockburn, Brighton, UK; Birgid Gonska, Bad Nauheim, DE; Vlasis Ninios, Thessaloniki, GR
Case Operator: Won-Keun Kim, University of Giessen & Marburg, Giessen, DE

Overview

Join leading experts for this hands-on symposium focused on optimising TAVI for long-term patient outcomes. This interactive session dives into critical techniques for lesion preparation, valve positioning and post-dilation, essential for managing larger annuli patients and ensuring lifetime procedural success.

Experience a live case demonstration and gain first-hand expertise from an experienced operator, showcasing how precise procedural strategies can impact valve durability, functionality and patient prognosis. Engage in real-time discussions, ask questions and refine your TAVI index procedure approach with specialist insights.

Agenda

• Welcome and Introduction – Rui Teles, Carnaxide, PT
• TAVI Procedure Optimisation: Lessons From the ACURATE IDE Study – James Cockburn, Brighton, UK
• Enhancing TAVI Outcomes: Precise Valve Placement and Implantation – Birgid Gonska, Bad Nauheim, DE
• Implications of Index Procedure Outcomes on Lifetime Patient Management – Vlasis Ninios, Thessaloniki, GR
• Case in Focus: TAVI for Larger Annuli Patients – Won-Keun Kim, Giessen, DE
• Panel Discussion and Q&A  – All

Learning objectives

• Recall the critical steps in lesion preparation and on post dilation to optimise valve implantation when needed
• Recognise the technical considerations in precise valve positioning and deployment for larger annuli patients
• Explore the long-term implications of index procedure optimisation on patient management and outcomes
• Engage with an expert operator through a live case demonstration and interactive discussion

This symposium is supported by an unrestricted educational grant from Boston Scientific.

*TAVI Index Procedure: The Value of Valve Optimisation on Long-term Outcomes and Lifetime Management has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME point, equating to 1 hour of learning. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.

Management of Degenerative MR With TEER: An Evidence-based Guide

Date: Saturday, 12 April 2025
Time: 19:05 CEST | 13:05 EDT

Chair: Tarun Chakravarty, Los Angeles, US
Panel: Firas Zahr, Portland, US; Tom Cahill, Oxford, UK

Overview

Join this interactive symposium to explore patient selection, device differentiation and key technical strategies for transcatheter edge-to-edge repair (TEER) in degenerative mitral regurgitation (DMR). Leading experts will dive into the growing unmet need for DMR treatment in the US, unpack the latest clinical data and share procedural insights through real-world case discussions.

Expect practical takeaways on device-specific features, technical precision and long-term clinical outcomes, all designed to elevate your approach to TEER. Don't miss this opportunity to engage with experts and refine your decision-making in DMR treatment.

Agenda

• Welcome and Introduction
• Transcatheter Repair: Selection in Degenerative MR
• Making Evidence-based Decisions in TEER – Insights From Recent Clinical Data
• Technical Considerations for TEER in DMR Patients
• Discussion and Q&A – All

Learning objectives

• Identify suitable patients for transcatheter repair over other treatments
• Recall long-term clinical outcomes for TEER in patients with DMR
• Select TEER devices based on design features and clinical data
• Review TEER implantation techniques

This symposium is supported by an unrestricted educational grant from Edwards Lifesciences.

*Management of Degenerative MR With TEER: An Evidence-based Guide’s programme will be submitted for CME accreditation.